Header Logo

Connection

DOV KADMON to T-Lymphocytes

Back to Details
This is a "connection" page, showing publications DOV KADMON has written about T-Lymphocytes.
DOV KADMON
Connection Strength
0.027
T-Lymphocytes
  1. HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer. Invest New Drugs. 2014 Apr; 32(2):235-242.
    View in: PubMed
    Score: 0.014
  2. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur Urol. 2005 Jul; 48(1):153-61.
    View in: PubMed
    Score: 0.008
  3. Gene therapy for prostate cancer. Urology. 2001 Jan; 57(1):8-16.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.